E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/5/2023 in the Prospect News Structured Products Daily.

New Issue: Barclays prices $2.21 million phoenix autocallable notes on ETFs

By Wendy Van Sickle

Columbus, Ohio, Oct. 5 – Barclays Bank plc priced $2.21 million of phoenix autocallable notes due Oct. 7, 2026 linked to the least performing of the ARK Innovation ETF and the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent monthly coupon at an annual rate of 14.5% if each underlier closes at or above its 60% coupon barrier on a related observation date.

The notes will be called at par plus the contingent coupon if each underlier closes at or above its initial level on any monthly call observation date after six months.

The payout at maturity will be par plus the final coupon if each underlier finishes at or above its coupon barrier.

If the worst performer finishes below its coupon barrier but at or above 50% of its initial value, the payout at maturity will be par. Otherwise, investors will lose 1% for each 1% decline of the worst performer from its initial level.

Barclays is the agent.

Issuer:Barclays Bank plc
Issue:Phoenix autocallable notes
Underlying assets:ARK Innovation Fund, SPDR S&P Biotech ETF
Amount:$2,205,000
Maturity:Oct. 7, 2026
Coupon:14.5% annualized, payable monthly if each underlier closes at or above coupon barrier on related observation date
Price:Par
Payout at maturity:Par plus final coupon if each underlier finishes at or above its coupon barrier; if worst performer finishes below its coupon barrier but at or above its final barrier, par; otherwise, 1% loss for each 1% decline of the worst performer from initial level
Call:Automatically at par plus contingent coupon if each underlier closes at or above initial level on any monthly call observation date after six months
Initial levels:$39.04 for ARK Innovation, $70.65 for SPDR S&P Biotech
Coupon barriers:$42.39 for ARK Innovation, $42.39 for SPDR S&P Biotech; 60% of initial levels
Final barriers:$19.52 for ARK Innovation, $35.33 for SPDR S&P Biotech; 50% of initial levels
Pricing date:Oct. 2
Settlement date:Oct. 5
Agent:Barclays
Fees:0.8%
Cusip:06745NN69

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.